Takuji Okusaka

Researcher Next ID · RN-004887

Researcher · Medicine

Tokyo, Japan

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Pancreatic and Hepatic Oncology Research

Cholangiocarcinoma and Gallbladder Cancer Studies

Hepatocellular Carcinoma Treatment and Prognosis

Cancer Genomics and Diagnostics

Gallbladder and Bile Duct Disorders

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
NEJM Evidence · 2022 · https://doi.org/10.1056/evidoa2200015
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.00808
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(18)30937-9
Genomic spectra of biliary tract cancer
Nature Genetics · 2015 · https://doi.org/10.1038/ng.3375
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1009290

No projects listed.